Medication info
Kiposin Tablet (Ciprofloxacin Hydrochloride Hydrate)

Kiposin Tablet (Ciprofloxacin Hydrochloride Hydrate)

Prescription medicationTabletOral
Ingredient · strength
Ciprofloxacin Hydrochloride Hydrate›291mg / 1 tablet
Manufacturer / importer
International Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 199200423 · Notified 1992.10.27 · Insurance code 643702190

Summary

Main use
Treatment of genitourinary, respiratory, ear, nose and throat, eye, gastrointestinal, skin, and osteoarticular infections
Who takes it
Adults
Adult dose
(Tablets) ○The usual adult dose is ciprofloxacin 250 ~ 500 mg per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days and continued for at least 3 days after symptoms disappear. ○Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formulas. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, even in severe renal impairment, the dose per administration may be increased up to 750 mg, but the patient's condition must be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.

Ingredients

Manufacturer
International Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of genitourinary, respiratory, ear, nose and throat, eye, gastrointestinal, skin, and osteoarticular infections

  • Acute bronchitis
  • respiratory infections
  • community-acquired pneumonia
  • pharyngitis
  • tonsillitis
  • laryngitis
  • otitis externa
  • chronic cholesteatomatous otitis media
  • chronic otitis media
  • bacterial prostatitis
  • acute uncomplicated cystitis
  • acute pyelonephritis
View approved original text

This medication is used to treat various bacterial infections. It is effective against respiratory infections and community-acquired pneumonia, except for acute bronchitis, and is also used for infections of the ear, nose, and throat. Additionally, it is suitable for treating bacterial prostatitis, acute uncomplicated cystitis, and pyelonephritis, as well as gonococcal cervicitis and urethritis. It can also be used for gastrointestinal infections, biliary tract infections, skin and soft tissue infections, and bone and joint infections. It is effective for gynecological infections, peritonitis, chalazion, and blepharitis. However, as a fluoroquinolone, it may cause serious adverse reactions, and should be used only when no other treatment options are available for specific mild infections. This medication is effectively used for treating various infections.

How to take

Adult dose

(Tablets) ○The usual adult dose is ciprofloxacin 250 ~ 500 mg per dose orally twice daily between meals. For severe complicated infections, the dose may be increased to 750 mg per dose twice daily. For acute infections, treatment is usually given for 5 ~ 10 days and continued for at least 3 days after symptoms disappear. ○Patients with renal impairment 1) Creatinine clearance > 50 mL/min: Administer the usual dose 2) 30 ~ 50 mL/mn: Administer 250 ~ 500 mg per dose twice daily 3) 5 ~ 29 mL/min: Administer 250 ~ 500 mg every 18 hours 4) Patients receiving hemodialysis or peritoneal dialysis: Administer 250 ~ 500 mg per dose once daily after dialysis 5) If only serum creatinine is known, creatinine clearance can be calculated using the following formulas. Men: {body weight (kg) × (140-age)}/ {72 × serum creatinine (mg/dL)} Women: 0.85 × the value calculated for men 6) For severe infections, even in severe renal impairment, the dose per administration may be increased up to 750 mg, but the patient's condition must be monitored carefully after administration. Adjust the dose as appropriate according to symptoms.

Precautions

This medication can cause serious side effects such as tendonitis or tendon rupture; if these symptoms occur, administration should be stopped immediately. It should not be used in patients with myasthenia gravis as symptoms may worsen. This medication is used only for certain bacterial infections and should be administered when no other treatment options are available. Caution is advised when used in elderly patients, patients with impaired renal function, or those with central nervous system disorders. Pregnant or breastfeeding women, children under 18 years of age, and individuals with epilepsy should avoid using this medication. This medication can interact with other drugs, so it is important to inform healthcare professionals of any concurrent medications. If symptoms such as skin rash, severe diarrhea, changes in mental state, visual disturbances, or difficulty breathing occur during treatment, consult a doctor immediately. Additionally, avoid strong sunlight or artificial UV exposure, and refrain from strenuous activity while taking this medication. Patients requiring blood sugar control should monitor their glucose levels frequently and seek treatment if hypoglycemic symptoms arise. Overdosage may cause kidney damage; therefore, it is important to adhere to the prescribed dosage and administration. Finally, this medication should be stored out of reach of children, protected from direct sunlight, and kept safe.

Side effects

Tendinitis, tendon rupture, peripheral neuropathy, central nervous system effect, exacerbation of myasthenia gravis, fungal superinfection, antibiotic-associated colitis, eosinophilia, thrombotic venous inflammation, leukopenia, anemia, neutropenia, leukocytosis, thrombocytopenia, thrombocytosis, erythrocytopenia, hemoglobin decrease, hematocrit decrease, granulocytopenia, leukolysis, hemolytic anemia, agranulocytosis, pancytopenia, bone marrow suppression, increased INR value, syndrome of inappropriate antidiuretic hormone secretion, allergic reactions, allergic edema, angioedema, anaphylactic reactions, anaphylaxis-like shock, serum sickness-like reactions, decreased appetite, decreased food intake, increased serum alkaline phosphatase, hyperglycemia, hypoglycemia, increased lipase, abnormal prothrombin levels, increased amylase, psychomotor agitation, anxiety, confusion, disorientation, emotional instability, abnormal dreams, depression, hallucinations, psychotic reactions, toxic psychosis, headache, dizziness, sleep disorders, taste disorders, insomnia, paresthesia, sensory decrease, loss of taste, tremors, convulsions, vertigo, mental confusion, seizures, drowsiness, migraine, coordination disorders, olfactory disorders, anosmia, sensory hypersensitivity, increased intracranial pressure, unable to coordinate movements, multifocal neuropathy, visual disturbances, color vision deficiency, diplopia, tinnitus, hearing loss, transient hearing loss, hearing impairment, tachycardia, vasodilation, hypotension, syncope, vasculitis, QT prolongation, ventricular tachycardia, Torsades de Pointes, dyspnea, laryngeal edema, nausea, diarrhea, anorexia, gastric discomfort, vomiting, gastrointestinal and abdominal pain, abdominal distension, dyspepsia, pseudomembranous colitis, stomatitis, oral candidiasis, gastrointestinal candidiasis, pancreatitis, abnormal liver function tests, increased bilirubin, hepatic dysfunction, jaundice, hepatitis, cholestatic jaundice, hepatic necrosis, rash, itching, urticaria, photosensitivity, vesicles, petechiae, erythema multiforme, Stevens-Johnson syndrome, toxic epidermal necrolysis, fixed drug eruption, acute generalized exanthematous pustulosis, arthralgia, musculoskeletal pain, myalgia, arthritis, increased muscle tension and cramps, joint swelling, muscle weakness, partial or complete tendon rupture, renal impairment, acute renal failure, hematuria, crystalluria, interstitial nephritis, vaginal candidiasis, undiagnosed pain, discomfort, fever, asthenia, edema, sweating, gait disturbances, maculopapular rash, purpura, acute respiratory distress, palpitations, abdominal or lower limb edema, muscle weakness, rhabdomyolysis, interstitial pneumonia, visual impairment, aneurysm, aortic dissection, valvular regurgitation, valvular insufficiency, shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture infiltration. This will help maintain its effectiveness for a longer period and prevent deterioration.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.